chlortetracycline

chlortetracycline is a lipid of Polyketides (PK) class. Chlortetracycline is associated with abnormalities such as Granulomatous Disease, Chronic, Infection, Ischemia, Cerebral Ischemia and Cerebral Infarction. The involved functions are known as Regulation, Binding (Molecular Function), Agent, Stimulus and Process. Chlortetracycline often locates in Protoplasm, Plasma membrane, Membrane, Cytoplasm and specific granule. The associated genes with chlortetracycline are FPR1 gene, P4HTM gene, Homologous Gene, HIST1H1C gene and Microbiome. The related lipids are Lysophosphatidylcholines, Sterols, dilauroyl lecithin, seminolipid and Total cholesterol. The related experimental models are Mouse Model.

Cross Reference

Introduction

To understand associated biological information of chlortetracycline, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with chlortetracycline?

chlortetracycline is suspected in Ischemia, Cerebral Ischemia, Cerebral Infarction, Granulomatous Disease, Chronic, Infection, Antibiotic resistant infection and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with chlortetracycline

MeSH term MeSH ID Detail
Blood Platelet Disorders D001791 12 associated lipids
Escherichia coli Infections D004927 17 associated lipids
Pasteurella Infections D010326 8 associated lipids
Swine Diseases D013553 16 associated lipids
Poultry Diseases D011201 21 associated lipids
Lymphadenitis D008199 8 associated lipids
Skin Diseases, Infectious D012874 7 associated lipids
Subacute Sclerosing Panencephalitis D013344 3 associated lipids
Synovitis D013585 15 associated lipids
Campylobacter Infections D002169 13 associated lipids
Per page 10 20 50 | Total 49

PubChem Associated disorders and diseases

What pathways are associated with chlortetracycline

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with chlortetracycline?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with chlortetracycline?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with chlortetracycline?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with chlortetracycline?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with chlortetracycline?

Mouse Model

Mouse Model are used in the study 'Chlortetracycline and demeclocycline inhibit calpains and protect mouse neurons against glutamate toxicity and cerebral ischemia.' (Jiang SX et al., 2005).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with chlortetracycline

Download all related citations
Per page 10 20 50 100 | Total 4669
Authors Title Published Journal PubMed Link
SAZ AK et al. Aureomycin-resistant cell-free nitro reductase from aureomycin-resistant Escherichia coli. 1956 J. Bacteriol. pmid:13319255
MACKAY IF et al. The influence of vitamin B12 and aureomycin upon the growth of protein-deficient children. 1956 J. Nutr. pmid:13320203
STERGAR S and NOVAK S [Not Available]. 1956 Ophthalmologica pmid:13322412
MILLER PA et al. Studies of chlorotetracycline biosynthesis and the preparation of chlorotetracycline-C14. 1956 Science pmid:13324139
CARDIA M et al. [Treatment and reinfection in vaginal trichomoniasis]. 1955 Acta Gynaecol Obstet Hisp Lusit pmid:13326218
LEWIS RA et al. Antibiotic dietary supplements in the therapy of childhood protein malnutrition. 1956 Am. J. Trop. Med. Hyg. pmid:13327183
HEULLY F [Medico-legal aspects of two accidental deaths caused by antibiotic therapy]. 1956 Mar-Apr Ann Med Leg Criminol Police Sci Toxicol pmid:13327534
SCHNEEGANS E et al. [Treatment of dyspepsia caused by specific colibacilli with framycetin; comparative study with other antibiotics]. 1956 Arch. Fr. Pediatr. pmid:13328181
PAVKOVIC-BUGARSKI G and CVETOJEVIC M [Biomicroscopic, microbiological and histopathological studies on the effect of aureomycin on trachoma]. 1956 Klin Monbl Augenheilkd Augenarztl Fortbild pmid:13332964
SOLSONA CONILLERA J [Acute viral hepatitis, treatment with aureomycin]. 1956 Med Cir Guerra pmid:13333489
PILLOT J and TRIBALAT A [Trisulfadiazine-aureomycin combination; its present value in human therapeutics]. 1956 Presse Med pmid:13335907
FOUCHET A [Reactions of identification of three tetracyclines]. 1956 Ann Pharm Fr pmid:13340470
FASSOTTE C [Moniliasis after administration of various antibiotics]. 1956 Arch Belg Dermatol Syphiligr pmid:13341021
FUGA GC [Case of dermatomyositis cured after aureomycin treatment]. 1955 Apr-Jun Soc Ital Dermatol Sifilogr Sezioni Interprov Soc Ital Dermatol Sifilogr pmid:13341780
GATE J et al. [Three cases of Dühring-Brocq disease successfully treated by a combination of aureomycin and nivaquine]. 1956 Mar-Apr Bull Soc Fr Dermatol Syphiligr pmid:13342802
GATE J et al. [Three new cases of Duhring-Brocq disease having benefited from combined aureomycin-nivaquine therapy]. 1956 Lyon Med pmid:13347212
COLOMB D and CAJGFINGER H [Duhring-Brocq disease treated by combined aureomycin-nivaquine and maintained by nivaquine alone]. 1956 Lyon Med pmid:13347214
ROBIOLA PF [Tetracycline; pharmaceutical forms and routes of administration]. 1956 Minerva Farm pmid:13348200
STEVENS AR Chlortetracycline in primary atypical pneumonia. 1956 Northwest Med pmid:13348971
ADLER P [Experiences with chlortetracycline therapy in odontogenic osteomyelitis]. 1956 Orv Hetil pmid:13349190
QUINTIN P and DULUC J [Trial of corticotherapy in Nicolas-Favre disease]. 1956 Presse Med pmid:13350136
DESMONTS T and CHAPON [Chlortetracycline in therapy of brucellosis in humans]. 1956 Rev Pathol Gen Physiol Clin pmid:13351172
DECIO R and ALAMANNI V [Transplacental passage of chlortetracycline (aureomycine)]. 1956 Riv Ostet Ginecol pmid:13351384
YAGI K et al. Inhibitory mechanism of chlortetracycline on D-amino acid oxidase. 1956 Science pmid:13351643
FREDERIKSEN T [Two fatal cases of micrococcal enteritis following antibiotic therapy]. 1956 Ugeskr. Laeg. pmid:13352533
Furuya S et al. Effects of modulators of protein kinases and phosphatases on mouse sperm capacitation. 1992 J. Assist. Reprod. Genet. pmid:1335315
GIBSON CD and THOMPSON WC The response of burn wound staphylococci to alternating programs of antibiotic therapy. 1955-1956 Antibiot Annu pmid:13355242
JAMPOL J et al. The efficacy of preoperative antibiotic bowel preparation. 1955-1956 Antibiot Annu pmid:13355249
BENSON WL et al. Compatibility of nicarbazin with antibiotics in high-level antibiotic feeds. 1955-1956 Antibiot Annu pmid:13355359
ALSON MC et al. The effect of feeding chlortetracycline to pigs with atrophic rhinitis. 1955-1956 Antibiot Annu pmid:13355360
RIZZI V [Combination of aureomycin and atabrine in therapy of pemphigus]. 1955 Oct-Dec Soc Ital Dermatol Sifilogr Sezioni Interprov Soc Ital Dermatol Sifilogr pmid:13355747
HOWARTH JA Effect of aureomycin and polyotic in an outbreak of leptospirosis of swine. 1956 J. Am. Vet. Med. Assoc. pmid:13357399
CAMPBELL JA and MURRAY TK Further studies on the effect of aureomycin on the apparent utilization of vitamin A by the rat. 1956 J. Nutr. pmid:13357967
FORBES RM and MEADE RJ The influence of chlortetracycline and vitamin B12, alone and in combination, on nitrogen utilization by growing swine. 1956 J. Nutr. pmid:13357979
ERSHOFF BH Beneficial effects of alfalfa, aureomycin and cornstarch on the growth and survival of hamsters fed highly purified rations. 1956 J. Nutr. pmid:13357988
SCHAPER J [Undesirable side-effects of wide range antibiotics on the physiologically obligate intestinal flora]. 1956 Z Haut Geschlechtskr pmid:13361324
COMPARISON of tetracycline with chlortetracycline in treatment of pneumonia; report from the City General Hospital, Sheffield. 1956 Br Med J pmid:13364403
ZAKI HA Pulmonary amoebiasis. 1956 Dis Chest pmid:13365502
BIERSCHWAL CJ and UREN AW The absorption of chlortetracycline (aureomycin) by the bovine uterus. 1956 J. Am. Vet. Med. Assoc. pmid:13366838
HARTSOOK EW A study of the effect of chlortetracycline (aureomycin) upon calcium retention by the growing male albino rat. 1956 J. Nutr. pmid:13367897
TRILLAT P [Preventive treatment of an abscess of the breast with aureomycin]. 1956 Lyon Med pmid:13368615
LEWIS D and TIDWELL RA Chlortetracycline for prophylaxis of streptococcal disease; a two year study. 1956 Northwest Med pmid:13369897
SCHUSTER A and SHWACHMAN H The tetracyclines; applied pharmacology. 1956 Pediatr. Clin. North Am. pmid:13370176
MONTILLI G and PISANI M [Use of tetracycline in dermatology]. 1955 Nov-Dec Rass Dermatol Sifilogr pmid:13370903
JUAREZ E [New evaluation of the treatment of Spanish relapsing fever with aureomycin]. 1956 Jun-Aug Rev Sanid Hig Publica (Madr) pmid:13371049
BLUHM HM et al. Use of antibiotics for the preservation of fish and sea foods. 1956 Am J Public Health Nations Health pmid:13372834
AUHAGEN H [Introduction of German standards for the antibiotics penicillin and aureomycin]. 1956 Arzneimittelforschung pmid:13373662
DE MAERTELAERE R [Not Available]. 1956 Brux Med pmid:13374401
MARTINEZ LM and SAZ AK Enzymatic basis of resistance to aureomycin. I. Differences between flavoprotein nitro reductases of sensitive and resistant Escherichia coli. 1956 J. Biol. Chem. pmid:13376597
MOLINA AA [Local treatment of superficial suppurating wounds with aureomycin solution]. 1956 Prensa Med Argent pmid:13379230